$MCHX

MARCHEX INC

Insider trades

No enriched coverage for $MCHX in the last 7 days.

No SEC Form 4 filings for $MCHX in the last 30 days.

See all $MCHX insider activity →
Med

MARCHEX INC (MCHX): Results of Operations and Financial Condition

MARCHEX INC (MCHX) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 mchx-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Marchex Announces Second Quarter 2026 Financial Results Reports Improved Profitability and Early Momentum Following Archenia Acquisition SEATTLE, WA – August 12, 2026 – Marchex, Inc. (NASDAQ: MCHX), a vertically focused, AI-d

MARCHEX INC (MCHX): Completion of Acquisition or Disposition of Assets

MARCHEX INC (MCHX) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. 8-K 0001224133 False 0001224133 2026-07-01 2026-07-01 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report ( Date of earliest event reported): July 1 ,

Marchex (MCHX) Reports Break-Even Earnings for Q3

Marchex (MCHX) delivered earnings and revenue surprises of -100.00% and -3.49%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

MCHX sentiment & insider activity

Recent MCHX coverage spans financial news, earnings and mergers & acquisitions.

What's driving MCHX

  • Fresh quarterly results and explicit pro forma Q3 2026 revenue and adjusted EBITDA ranges create a near-term valuation and positioning catalyst for MCHX.

    SEC EDGAR 8-K · Aug 12, 2026

  • Deal close adds near-term balance-sheet/financing overhang via convertible notes, plus dilution/earnout-like share issuance tied to Archenia revenue/Adjusted EBITDA and retention targets.

    SEC EDGAR 8-K · Jul 1, 2026

  • Marchex (MCHX) reported break-even earnings for Q3 2025, with earnings surprises of -100% and revenue surprises of -3.49%. The lack of earnings growth and negative surprises suggest limited short-term upside, but the stock's reaction will depend on investor expectations and future guidance.

    Zacks Commentary · Nov 13, 2025

  • Marchex (MCHX) has reported Q3 2025 earnings with a somewhat bullish sentiment. The company's outlook appears optimistic, potentially supporting a short-term price increase.

    Motley Fool · Nov 13, 2025

  • Marchex (MCHX) reported Q2 earnings and revenue significantly exceeding expectations, with earnings surging +300%. This positive surprise indicates strong operational performance, which could support a short-term stock rally.

    Zacks Commentary · Aug 12, 2025

alphai scores every news story that mentions MCHX with an AI model for sentiment and relevance, and aggregates insider trades from MARCHEX INC's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $MCHX

Score
$MCHXMed

MARCHEX INC (MCHX): Results of Operations and Financial Condition

MARCHEX INC (MCHX) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 mchx-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Marchex Announces Second Quarter 2026 Financial Results Reports Improved Profitability and Early Momentum Following Archenia Acquisition SEATTLE, WA – August 12, 2026 – Marchex, Inc. (NASDAQ: MCHX), a vertically focused, AI-d

MARCHEX INC (MCHX): Completion of Acquisition or Disposition of Assets

MARCHEX INC (MCHX) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. 8-K 0001224133 False 0001224133 2026-07-01 2026-07-01 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report ( Date of earliest event reported): July 1 ,

Related tickers